Coeptis Therapeutics Holdings CEO David Mehalick's 2022 pay jumps 67% to $362K
Coeptis Therapeutics Holdings reports 2022 executive compensation
By ExecPay News
Published: November 17, 2023
Coeptis Therapeutics Holdings reported fiscal year 2022 executive compensation information on November 17, 2023.
In 2022, three executives at Coeptis Therapeutics Holdings received on average a compensation package of $316K, a 71% increase compared to previous year.
Average pay of disclosed executives at Coeptis Therapeutics Holdings
David Mehalick, Chief Executive Officer, received $362K in total, which increased by 67% compared to 2021. 79% of Mehalick's compensation, or $287K, was in salary. Mehalick also received $75K in bonus.
Daniel Yerace, Vice President of Operations, received a compensation package of $360K, which increased by 76% compared to previous year. 79% of the compensation package, or $285K, was in salary.
Christine Sheehy, Chief Financial Officer, earned $226K in 2022, a 69% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on November 17, 2023.